Amgen (AMGN) Debt Ratio (2009 - 2026)
Amgen (AMGN) posted quarterly Debt Ratio of 0.62 for Q1 2026, down 3.49% year-over-year from 0.64 in Q1 2025, and up 2.8% on a QoQ basis from 0.6 in Q4 2025.
Amgen (AMGN) Debt Ratio (2009 - 2026) Analysis & Trends
Amgen (AMGN) has reported Debt Ratio for 18 consecutive years, with 0.62 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio fell 3.49% year-over-year to 0.62; the TTM figure through Mar 2026 stood at 0.62 (down 3.49% YoY), while the FY2025 annual figure was 0.6, down 7.89% from the prior year.
- Debt Ratio came in at 0.62 for Q1 2026 at Amgen, up from 0.6 in the prior quarter.
- The five-year high for Debt Ratio was 0.69 in Q1 2023, with the low at 0.6 in Q4 2022.
- Average Debt Ratio over 5 years is 0.64, with a median of 0.64 recorded in 2025.
- Across the five-year window, Debt Ratio rose 19.12% in 2022 and decreased 8.88% in 2025, its largest moves.
- Year by year, Debt Ratio stood at 0.6 in 2022, then climbed by 11.21% to 0.67 in 2023, then dropped by 1.6% to 0.65 in 2024, then slipped by 7.89% to 0.6 in 2025, then rose by 2.8% to 0.62 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.62, 0.6, and 0.61 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.37 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.27 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.47 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -0.21 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.38 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.62 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.39 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.31 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 0.61 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 0.64 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.66 |
| Jun 30, 2024 | 0.69 |
| Mar 31, 2024 | 0.69 |
| Dec 31, 2023 | 0.67 |
| Sep 30, 2023 | 0.67 |
| Jun 30, 2023 | 0.68 |
| Mar 31, 2023 | 0.69 |
| Dec 31, 2022 | 0.60 |
| Sep 30, 2022 | 0.61 |
| Jun 30, 2022 | 0.62 |
| Mar 31, 2022 | 0.62 |
| Dec 31, 2021 | 0.54 |
| Sep 30, 2021 | 0.58 |
| Jun 30, 2021 | 0.55 |